S.No. |
Compound |
Reference |
Improved potential |
Physicochemical Properties and Toxicity Risks |
1 |
Palmatine | Vasanthi and Kannan, 2012 | Anti-adipogenic activity |
Properties and Risk Assessment |
2 |
Quercetin | Ahn,et al., 2008 | Anti-adipogenic activity |
Properties and Risk Assessment |
3 |
Salicylic acid | Rena and Sakamoto, 2014 | Anti-inflammatory activity |
Properties and Risk Assessment |
4 |
Rutin | Niture et al., 2014 | Anti-inflammatory activity |
Properties and Risk Assessment |
5 |
Carnosol | Rau et al., 2006 | Anti-inflammatory activity |
Properties and Risk Assessment |
6 |
Diallyl disulphide | Liu et al., 2006 | Anti-inflammatory activity |
Properties and Risk Assessment |
7 |
Curcumin | Weisberg et al., 2008 Meng et al., 2013 | Anti-inflammatory activity |
Properties and Risk Assessment |
8 |
6-Gingerol | Chakraborty et al., 2012 Gao et al., 2009 | Anti-inflammatory activity |
Properties and Risk Assessment |
9 |
Oleanolic acid | Castellano et al., 2013 | Anti-inflammatory activity |
Properties and Risk Assessment |
10 |
Naringin | Mahmoud et al., 2012 | Anti-inflammatory activity |
Properties and Risk Assessment |
11 |
Hesperidin | Mahmoud et al., 2012 | Anti-inflammatory activity |
Properties and Risk Assessment |
12 |
Cyanidin-3-glucoside | Matsukawa et al., 2015 | Anti-inflammatory activity |
Properties and Risk Assessment |
13 |
Epigallocatechin Gallate | Zhang et al., 2011 | Anti-inflammatory activity |
Properties and Risk Assessment |
14 |
Neohydnocarpin | Sharma and Hall, 1991 | Anti-inflammatory activity |
Properties and Risk Assessment |
15 |
Sulforaphane | Negi et al., 2011 | Anti-inflammatory activity |
Properties and Risk Assessment |
16 |
Sodium salicylate | Jiang et al., 2015 | Anti-inflammatory activity |
Properties and Risk Assessment |
17 |
Ginsenoside Re | Nauck et al., 2004 | Anti-inflammatory activity |
Properties and Risk Assessment |
18 |
Beta-sitosterol | Gupta et al., 2011 | Antioxidant Potential |
Properties and Risk Assessment |
19 |
Lycopene | Vallero et al., 2011 | Antioxidant Potential |
Properties and Risk Assessment |
20 |
Salidroside | Li et al., 2011 | Antioxidant Potential |
Properties and Risk Assessment |
21 |
Kolaviron | Ayepola et al., 2014 | Antioxidant Potential |
Properties and Risk Assessment |
22 |
Stigmasterol | Panda et al., 2009 | Antioxidant Potential |
Properties and Risk Assessment |
23 |
Inulin | Gargari et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
24 |
Rutin | Kamalakkannan and Prince, 2006 | Antioxidant Potential |
Properties and Risk Assessment |
25 |
Lupeol | Gupta et al., 2011 Gupta et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
26 |
Thymoquinone | Kanter, 2009 | Antioxidant Potential |
Properties and Risk Assessment |
27 |
Epigallocatechin Gallate | Zhang et al., 2011 | Antioxidant Potential |
Properties and Risk Assessment |
28 |
Cinnamaldehyde | Subash Babu et al., 2014 | Antioxidant Potential |
Properties and Risk Assessment |
29 |
Neferine | Guan et al., 2014 | Antioxidant Potential |
Properties and Risk Assessment |
30 |
Vicine | Ali et al., 2014 | Antioxidant Potential |
Properties and Risk Assessment |
31 |
alpha-tocopherol | Garg et al., 2005 | Antioxidant Potential |
Properties and Risk Assessment |
32 |
Gallic acid | Punithavathi et al., 2011 | Antioxidant Potential |
Properties and Risk Assessment |
33 |
Resveratrol | Szkudelski and Szkudelska, 2011 | Antioxidant Potential |
Properties and Risk Assessment |
34 |
Piperine | Rauscher et al., 2000 | Antioxidant Potential |
Properties and Risk Assessment |
35 |
Pipernonaline | Manoharan et al., 2007 | Antioxidant Potential |
Properties and Risk Assessment |
36 |
Mangiferin | Sellamuthu et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
37 |
Proanthocyanidin | Mansouri et al., 2015 | Antioxidant Potential |
Properties and Risk Assessment |
38 |
Gallotannin | D'souza et al., 2014 | Antioxidant Potential |
Properties and Risk Assessment |
39 |
Estrogen | Ahmed and Hassanein, 2012 | Antioxidant Potential |
Properties and Risk Assessment |
40 |
Myricetin | Ozcan et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
41 |
Thymol | Manzari-Tavakoli et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
42 |
Solasonine | Vasuki, et al., 2014 | Antioxidant Potential |
Properties and Risk Assessment |
43 |
Diallyl disulphide | Liu et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
44 |
S-allyl cysteine | Yang et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
45 |
Bergenin | Kumar et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
46 |
Lipoic acid | Golbidi et al., 2011 | Antioxidant Potential |
Properties and Risk Assessment |
47 |
Quercetin | Anjaneyulu and Chopra, 2004 Bansal et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
48 |
S-allyl cysteine Sulfoxide | Augusti and Sheela, 1996 | Antioxidant Potential |
Properties and Risk Assessment |
49 |
Emblicanin-A | Scartezzini and Speroni, 2000 | Antioxidant Potential |
Properties and Risk Assessment |
50 |
Punigluconin | Usharani et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
51 |
Emblicanin-B | Dutta and Sahu., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
52 |
Curcumin | Weisberg et al., 2008 Meng et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
53 |
6-Gingerol | Chakraborty et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
54 |
Oleanolic acid | Castellano et al., 2013 Gao et al., 2009 | Antioxidant Potential |
Properties and Risk Assessment |
55 |
Ferulic acid | Balasubhashini et al., 2004 | Antioxidant Potential |
Properties and Risk Assessment |
56 |
Naringin | Kandhare et al., 2012 Ali and Kader et al., 2004 | Antioxidant Potential |
Properties and Risk Assessment |
57 |
Isorhamnetin | Yokozawa et al., 2002 | Antioxidant Potential |
Properties and Risk Assessment |
58 |
Hesperidin | Mahmoud et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
59 |
Astaxanthin | Naito et al., 2004 | Antioxidant Potential |
Properties and Risk Assessment |
60 |
Pterostilbene | Saandtheesh and Pari et al., 2006 | Antioxidant Potential |
Properties and Risk Assessment |
61 |
Chicoric acid | Xiao et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
62 |
Citronellol | Jagdale et al., 2015 | Antioxidant Potential |
Properties and Risk Assessment |
63 |
D-limonene | Murali et al., 2013 | Antioxidant Potential |
Properties and Risk Assessment |
64 |
Trigonelline | Zhou et al., 2012 | Antioxidant Potential |
Properties and Risk Assessment |
65 |
p-coumaric acid | Amalan and Vijayakumar, 2015 | Antioxidant Potential |
Properties and Risk Assessment |
66 |
S-allyl mercaptocysteine | Borek, 2001 | Antioxidant Potential |
Properties and Risk Assessment |
67 |
Delphinidin chloride | Bertuglia et al., 1995 | Antioxidant Potential |
Properties and Risk Assessment |
68 |
L-tryptophan | MacIndoe and Turkington, 1973 | Hormonal Imbalance |
Properties and Risk Assessment |
69 |
Hydnowightin | Sharma and Hall, 1991 | Hypo-lipidemic property |
Properties and Risk Assessment |
70 |
Neohydnocarpin | Sharma and Hall, 1991 | Hypo-lipidemic property |
Properties and Risk Assessment |
71 |
Emblicanin-A | Scartezzini and Speroni, 2000 | Hypo-lipidemic property |
Properties and Risk Assessment |
72 |
Cinnamaldehyde | Babu,2007 | Hypo-lipidemic property |
Properties and Risk Assessment |
73 |
Punigluconin | Usharani et al., 2013 | Hypo-lipidemic property |
Properties and Risk Assessment |
74 |
Allyl propyl disulfide | Augusti et al., 1974 | Hypo-lipidemic property |
Properties and Risk Assessment |
75 |
Coumarin | Verma et al., 2013 | Hypo-lipidemic property |
Properties and Risk Assessment |
76 |
Kotalagenin 16-acetate | Stohs and Ray, 2015 | Hypo-lipidemic property |
Properties and Risk Assessment |
77 |
Salaprinol | Stohs and Ray, 2015 | Hypo-lipidemic property |
Properties and Risk Assessment |